Skip to main content

CVE detail

CVE-2020-3961

VMware Horizon Client for Windows (prior to 5.4.3) contains a privilege escalation vulnerability due to folder permission configuration and unsafe loading of libraries. A local user on the system where the software is installed may exploit this issue to run commands as any user.

CVSS 7.8 · HighBuzz score 11.9

Buzz score

Why this CVE is surfacing

Buzz score total 11.9

This all-time snapshot uses the same composite formula as Trending across a 30-year evidence window, rather than a current rolling window.

Buzz score components · mention 6.9 · diversity 5.0 · KEV 0.0 · OTX 0.0 · PoC 0.0
Mention score
6.9
1 evidence mentions in the snapshot
Diversity score
5.0
1 sources across 1 categories
KEV score
0.0
No KEV entry observed
OTX score
0.0
0 OTX pulses
PoC score
0.0
0 repos · best confidence N/A
Best PoC traction
0
Maximum stars on a matched PoC repo

Why it matters now

Mention timeline

Total mentions
0
within the 30d window
Peak daily
0
highest bucket

Evidence

Source links by recency

Newest mentions first
1 source links · newest first
  • VMware has addressed a high-severity information disclosure vulnerability affecting its Workstation, Fusion and vSphere virtualization products. VMware has addressed a high-severity information disclosure vulnerability, tracked as CVE-2020-3960, that affects its Workstation, Fusion and vSphere virtualization products. The CVE-2020-3960 flaw was discovered by Cfir Cohen, a researcher from Google’s cloud security team. ESXi, Workstation and Fusion […]

    newssecurityaffairs.comJun 10, 2020, 11:41 PM

Exploit code

Public exploit repository references

Public PoC repositories are third-party, potentially unsafe artifacts. Treat their code as untrusted and use it only on authorized systems in an isolated, least-privilege environment. cvebuzz does not execute the code or verify that an exploit works.

0 repository references · best confidence N/A · max 0 stars
No public PoC repositories have been matched yet.

Related records

Similar CVEs

6 related CVEs with shared weakness or product evidence